Showing 2541-2550 of 3223 results for "".
- iSTAR Medical to Present New 3-Year STAR-GLOBAL Data at World Glaucoma Congresshttps://modernod.com/news/istar-medical-to-present-new-3-year-star-global-data-at-world-glaucoma-congress/2481683/iSTAR Medical announced that it will be hosting a symposium where it will present 3-year interim data from the STAR-GLOBAL trial and will also be running a dry lab at its booth at the 10th World Glaucoma Congress (WGC) taking place in Rome, Italy from June 28 to July 1, 2023.
- Ocular Therapeutix Announces 12-Month Topline Data from Ongoing Phase 1 Trial Evaluating OTX-TKI for Wet AMDhttps://modernod.com/news/ocular-therapeutix-announces-12-month-topline-data-from-ongoing-phase-1-trial-evaluating-otx-tki-for-wet-amd/2481669/Ocular Therapeutix announced 12-month data from its phase 1 US clinical trial evaluating OTX-TKI, the company’s axitinib intravitreal hydrogel implant, for the treatment of wet age-related macular degeneration (AMD). OTX-TKI is also being developed for the treatment of diabetic retinop
- MediPrint Ophthalmics Announces Results from its SIGHT-2 Phase 2b Group 1 Clinical Studyhttps://modernod.com/news/mediprint-ophthalmics-announces-results-from-its-sight-2-phase-2b-group-1-clinical-study/2481665/MediPrint Ophthalmics announced it has completed its SIGHT-2 dose-finding phase 2b Group 1 (low dose) study for its proprietary drug-eluting contact lens for glaucoma. This is the first of potentially three doses in the second study of its clinical program SIGHT (Sustained Innovati
- Apple Provides New Vision Health Features on iOS 17, iPadOS 17, and WatchOS 10https://modernod.com/news/apples-provides-new-vision-health-features-on-ios-17-ipados-17-and-watchos-10/2481655/Apple announced new health features in iOS 17, iPadOS 17, and watchOS 10, expanding into mental health and vision health and providing innovative tools and experiences across platforms. New mental health features allow users to log their momentary emotions and daily moods
- AOS Launches Remote Visual Acuity System Platformhttps://modernod.com/news/aos-launches-remote-visual-acuity-system-platform/2481652/AOS (Advanced Ophthalmic Systems) announced the launch of a new remote visual acuity software platform. The AOS VA software is a synchronous test that requires internet connection and can be used on multiple device types. Using a combination of semi-automated test algorithms a
- Bausch + Lomb Launches Infuse Multifocal Silicone Hydrogel Contact Lenses in the United Stateshttps://modernod.com/news/bausch-lomb-launches-infuse-multifocal-silicone-hydrogel-contact-lenses-in-the-united-states/2481649/Bausch + Lomb announced the US launch of Bausch + Lomb Infuse Multifocal silicone hydrogel (SiHy) daily disposable contact lenses. Featuring a new material infused with ProBalance Technology for all-day comfort and the company’s '3-Zone Progressive' design,
- Coave Therapeutics Announces Positive 12-Month Data from Ongoing Phase 1/2 Clinical Trial of Investigational RP Drughttps://modernod.com/news/coave-therapeutics-announces-positive-12-month-data-from-ongoing-phase-12-clinical-trial-of-investigational-rp-drug/2481640/Coave Therapeutics announced positive 12-month results from its phase 1/2 trial evaluating the safety and efficacy of its gene therapy, CTx-PDE6b, for retinitis pigmentosa (RP) caused by bi-allelic mutations in the PDE6B gene (PDE6b RP). These positive data support C
- AI Used to Advance Drug Delivery System for Glaucoma and Other Chronic Diseaseshttps://modernod.com/news/ai-used-to-advance-drug-delivery-system-for-glaucoma-and-other-chronic-diseases/2481636/Researchers from Wilmer Eye Institute, Johns Hopkins Medicine say they have used artificial intelligence models and machine-learning algorithms to successfully predict which components of amino acids that make up therapeutic proteins are most likely to safely deliver therapeutic drugs to animal e
- Partnership Agreement Between Mireca and Graybug Terminatedhttps://modernod.com/news/partnership-agreement-between-mireca-and-graybug-terminated/2481631/Mireca Medicines announced that the partnership agreement between Mireca and Graybug (now CalciMedica) has been terminated due to a shift in drug development focus of CalciMedica away from ocular diseases. As part of the termination, all intellectual property rights that
- International Sports Vision Association Launches "Ask a Sports Vision Expert" Featurehttps://modernod.com/news/international-sports-vision-association-launches-ask-a-sports-vision-expert-feature/2481622/A growing body of evidence confirms that visual abilities can be strengthened and enhanced by means of appropriate visual training. Sports vision, the science of helping athletes reach peak levels of performance through enhancement of visual skills, is becoming more important in training for all